期刊文献+

Recurrence risk model for esophageal cancer after radical surgery 被引量:12

Recurrence risk model for esophageal cancer after radical surgery
暂未订购
导出
摘要 Objective:The aim of the present study was to construct a risk assessment model which was tested by disease-free survival (DFS) of esophageal cancer after radical surgery.Methods:A total of 164 consecutive esophageal cancer patients who had undergone radical surgery between January 2005 and December 2006 were retrospectively analyzed.The cutpoint of value at risk (VaR) was inferred by stem-and-leaf plot,as well as by independent-samples t-test for recurrence-free time,further confirmed by crosstab chi-square test,univariate analysis and Cox regression analysis for DFS.Results:The cutpoint of VaR was 0.3 on the basis of our model.The rate of recurrence was 30.3 % (30/99)and 52.3% (34/65) in VaR <0.3 and VaR >0.3 (chi-square test,x2 =7.984,P=0.005),respectively.The 1-,3-,and 5-year DFS of esophageal cancer after radical surgery was 70.4%,48.7%,and 45.3%,respectively in VaR >≥0.3,whereas 91.5%,75.8%,and 67.3%,respectively in VaR <0.3 (Log-rank test,x2 =9.59,P=0.0020),and further confirmed by Cox regression analysis [hazard ratio =2.10,95 % confidence interval (CI):1.2649-3.4751; P=0.0041].Conclusions:The model could be applied for integrated assessment of recurrence risk after radical surgery for esophageal cancer. Objective:The aim of the present study was to construct a risk assessment model which was tested by disease-free survival (DFS) of esophageal cancer after radical surgery.Methods:A total of 164 consecutive esophageal cancer patients who had undergone radical surgery between January 2005 and December 2006 were retrospectively analyzed.The cutpoint of value at risk (VaR) was inferred by stem-and-leaf plot,as well as by independent-samples t-test for recurrence-free time,further confirmed by crosstab chi-square test,univariate analysis and Cox regression analysis for DFS.Results:The cutpoint of VaR was 0.3 on the basis of our model.The rate of recurrence was 30.3 % (30/99)and 52.3% (34/65) in VaR <0.3 and VaR >0.3 (chi-square test,x2 =7.984,P=0.005),respectively.The 1-,3-,and 5-year DFS of esophageal cancer after radical surgery was 70.4%,48.7%,and 45.3%,respectively in VaR >≥0.3,whereas 91.5%,75.8%,and 67.3%,respectively in VaR <0.3 (Log-rank test,x2 =9.59,P=0.0020),and further confirmed by Cox regression analysis [hazard ratio =2.10,95 % confidence interval (CI):1.2649-3.4751; P=0.0041].Conclusions:The model could be applied for integrated assessment of recurrence risk after radical surgery for esophageal cancer.
出处 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2013年第5期549-555,共7页 中国癌症研究(英文版)
关键词 Esophageal cancer radical surgery RECURRENCE MODEL Esophageal cancer radical surgery recurrence model
  • 相关文献

参考文献24

  • 1Kleinberg L, Forastiere AA. Chemoradiation in the management of esophageal cancer. J Clin Oncol 2007;25:4110-7.
  • 2Hulscher JB, van Sandick JW, Tijssen JG, et al. The recurrence pattern of esophageal carcinoma after transhiatal resection. J Am Coil Surg 2000; 191:143-8.
  • 3Mariette C, Balon JM, Piessen G, et al. Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer 2003;97:1616-23.
  • 4Chen G, Wang Z, Liu XY, et al. Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esophagectomy. World J Surg 2007;31:1107-14.
  • 5Lu JC, Kong C, Tao H. Radiotherapy with or without concurrent chemotherapy for lymph node recurrence after radical surgery of thoracic esophageal squamous cell carcinoma. IntJ Radiat Oncol Biol Phys 2010;78:710-4.
  • 6Rizk NP, Ishwaran H, Rice TW, et al. Optimum lymphadenectomy for esophageal cancer. Ann Surg 2010;251:46-50.
  • 7Merkow RP, Bilimoria KY, Chow WB, et al. Variation in lymph node examination after esophagectomy for cancer in the United States. Arch Surg 2012;147:505-11.
  • 8Peyre CG, Hagen JA, DeMeester SR, et al. Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes. Ann Surg 2008;248:979-85.
  • 9Rice TW, Rusch Ishwaran H, et al. Cancer of the esophagus and esophagogastric junction: data-driven stagingfor the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals. Cancer 2010;116:3763-73.
  • 10Yang HX, Xu Y, Fu JH, et al. An evaluation of the number of lymph nodes examined and survival for node-negative esophageal carcinoma: data from China. Ann Surg Oncol 2010;17:1901-11.

同被引文献55

引证文献12

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部